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DPY-30 is a subunit of mammalian COMPASS-like
complexes (complex of proteins associated with
Set1) and regulates global histone H3 Lys-4 trimethy-
lation. Here we report structural evidence showing
that the incorporation of DPY-30 into COMPASS-
like complexes is mediated by several hydrophobic
interactions between an amphipathic a helix located
on the C terminus of COMPASS subunit ASH2L and
the inner surface of the DPY-30 dimerization/docking
(D/D) module. Mutations impairing the interaction
between ASH2L and DPY-30 result in a loss of his-
tone H3K4me3 at the b locus control region and
cause a delay in erythroid cell terminal differentia-
tion. Using overlay assays, we defined a consensus
sequence for DPY-30 binding proteins and found
that DPY-30 interacts with BAP18, a subunit of the
nucleosome remodeling factor complex. Overall,
our results indicate that the ASH2L/DPY-30 complex
is important for cell differentiation and provide in-
sights into the ability of DPY-30 to associate with
functionally divergent multisubunit complexes.
INTRODUCTION
Histone proteins are essential scaffolding factors contributing to
the high level of DNA densification in eukaryotes. Changes in the
chromatin landscape by ATP-dependent chromatin remodeling
complexes, the loading of histone variants, DNA methylation,
and posttranslational modifications (PTMs) of histone proteins
represent different means of regulating DNA-based transactions
(Banaszynski et al., 2010; Cedar and Bergman, 2012; Goldberg
et al., 2007; Sadeh and Allis, 2011). Among these mechanisms,
PTMs deposited on histones H3, H4, H2A, or H2B are important
factors controlling the structural reorganization of chromatin orStructure 22, 1821–18forming binding platforms for the recruitment of various multisu-
bunit protein complexes.
Cell-specific transcription patterns are important for relaying
the proper cues to determine the timing or fate of cell differenti-
ation, which is in part controlled by specific histone PTMs,
such as histone H3 Lys-4 (H3K4) methylation. Members of the
SET1 family of histone methyltransferases, which site-specif-
ically methylate H3K4 (Couture and Skiniotis, 2013; Shilatifard,
2008), are closely associated with different differentiation pro-
grams. For example, MLL2-containing complexes bind to the
b-globin locus control region (LCR) and maintain a high level of
expression of the b-globin gene, a marker for terminal erythroid
differentiation (Demers et al., 2007). The same enzyme is also
important in the establishment of bivalent promoters in embry-
onic stem cells (Hu et al., 2013). The recruitment of SET1 by
USF1 is key for mesoderm specification and lineage differentia-
tion (Deng et al., 2013). Combined with studies showing that
deletion of MLL1 leads to embryonic lethality (Yu et al., 1995),
these findings demonstrate that members of the SET1 family of
methyltransferases play crucial roles during development.
Evolutionary conserved, the members of the SET1 family
of methyltransferases reside in multisubunit complexes with a
common four-subunit complex composed of WDR5, RbBP5,
ASH2L, and DPY-30 (referred to as WRAD). Although WRAD
stabilizes and stimulates the enzymatic activity of all SET1 mem-
bers, each subunit plays distinct roles. WDR5 binds a VDV motif
on RbBP5 (Avdic et al., 2011; Chen et al., 2012; Odho et al., 2010)
as well as the WDR5-interacting motif region of all SET1 mem-
bers to fully stimulate the enzymatic activity of these enzymes
(Dharmarajan et al., 2012; Zhang et al., 2012). In addition, binding
of the ASH2L SPIa and Ryanodine receptor domain to RbBP5
creates a binding platform that directly interacts with and stimu-
lates the enzymatic activity of the MLL1 SET domain (Cao et al.,
2010; Chen et al., 2012). Recent cryoelectron microscopy (cryo-
EM) analysis of yeast (and human) core complex of proteins
associated with Set1 (COMPASS) supported these crystallo-
graphic studies, revealing that Cps60 (ASH2L homolog) and
Cps25 (DPY-30 homolog) form a globular structure sitting at
the base of the Y-shaped COMPASS structure sandwiching,30, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1821
Figure 1. ASH2LSDI Binds to the DPY-30D/D
Module as an Amphipathic a Helix
(A) Schematic representation of DPY-30 and
ASH2L. Each functional domain is highlighted
differently, and the numbering of ASH2L residues
is based on the isoform 3 reported in the Uniprotkb
database. WH, winged helix.
(B) Optimization of the overlay assay. Indicated are
peptide sequences tested in our initial overlay
assay. Shown is a processed image of the LICOR
analysis of GST-DPY-30 binding to a small array
containing peptides corresponding to ASH2LSDI.
The star denotes peptides harboring substitutions
of each leucine residue for an aspartic acid. A
heatmap representation of the quantification is
shown below the array. Deviations higher than 1
above the WT are represented by different shades
of blue. Dark blue, >10-fold; blue, >5-fold; light
blue, >3-fold.
(C) Crystal structure of ASH2LSDI in complex with
DPY-30D/D. DPY-30 a helices of protomers A and
B are colored in green and gray, respectively,
whereas ASH2SDI is highlighted in beige (left).
Shown is the electrostatic surface potential of
the DPY-30D/D crystal structure in complex with
ASH2LSDI (right). Electrostatic potentials are con-
toured from +10kbTe
1 (blue) to 10 kbTe1 (red).
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DPY-30 Binds the NURF and COMPASS-like Complexesalong with the Cps50 (RbBP5 homolog)/Cps35 (WDR5 homolog)
heterodimer, the catalytic domain of SET1 (Takahashi et al.,
2011). Consistent with the role of SET1 members in develop-
mental biology, the depletion of subunits regulating H3K4 meth-
yltransferases such as WDR5 results in a global loss of histone
H3K4 methylation and concomitant loss of Hox gene expression
in human embryonic kidney 293 (HEK293) cells (Dou et al., 2006).
Similarly, knockdown of DPY-30 and ASH2L leads to a defect in
neural lineage formation by embryonic stem cells (Jiang et al.,
2011) and incomplete differentiation of myogenic precursors,
respectively (Rampalli et al., 2007).
DPY-30 is an important subunit of COMPASS as well as
mammalian COMPASS-like complexes. Knockdown of DPY-
30 in fibroblasts leads to a senescent phenotype (Simboeck
et al., 2013), and deletion of Cps25 in Saccharomyces cerevisiae
(also known as Sdc1 or SAF19) results in a global loss of H3K4
trimethylation (H3K4me3) (South et al., 2010). The role of DPY-
30 is in part controlled by its ability to bind the C terminus of
ASH2L, a motif that was coined as Sdc1 DPY-30 interacting re-
gion (SDI) (South et al., 2010). Initial crystallographic studies re-
vealed that residues 45–99 of DPY-30 fold as three antiparallel a
helices forming an X bundle showing striking structural homol-
ogy to the dimerization/docking (D/D) domain of protein kinase
A (PKA) regulatory (R) domains (Wang et al., 2009). However,
the lack of structural data for DPY-30 bound to ASH2L has hin-
dered our understanding of the molecular basis for binding
selectivity, formation of the ASH2L/DPY-30 complex, and struc-
tural determinants underlying the role of this heterodimer in cell
differentiation.
To understand the structural basis underlying the binding of
DPY-30 to ASH2L, we determined the crystal structure of the
DPY-30 D/D module (DPY-30D/D) in complex with a fragment
corresponding to residues 509–524 of ASH2L (referred to as
ASH2LSDI). Mutations of residues forming the DPY-30D/D-1822 Structure 22, 1821–1830, December 2, 2014 ª2014 Elsevier LtdASH2LSDI interface result in a decrease of H3K4 trimethylation
at the b-globin gene and concomitant reduction of b-globin
expression in differentiated erythroid cells. In parallel, our overlay
assays reveal the ability of DPY-30D/D to accommodate different
amphipathic a helices and suggest that DPY-30 is a subunit of
several protein complexes, including the nucleosome remodel-
ing factor (NURF) complex, an ATP-dependent chromatin re-
modeler and a bona fide reader of H3K4me3, a mark controlled
by DPY-30.
RESULTS
Overall Structure
Previousstudieshaveshown thatDPY-30D/Dbinds theC terminus
ofASH2L (South et al., 2010; Figure 1A). Tofirst define theminimal
structural determinants underlying the formation of the DPY-30/
ASH2L complex, GST-DPY-30 was incubated with ASH2L
peptidescrosslinked toamembrane.Asshown inFigure1B, incu-
bationofGST-DPY-30withpeptidescorresponding to thevarious
regions of the ASH2L C terminus reveals that DPY-30 preferably
binds ASH2L503–523. Consistent with previous biochemical
studies (Chen et al., 2012), replacement of ASH2L hydrophobic
residues with aspartic acid residues severely impairs the binding
of DPY-30. Taken together, these results show that ASH2L resi-
dues 503–523 are important for DPY-30 binding.
To understand how ASH2L binds DPY-30, we solved the crys-
tal structure of DPY-30D/D (residues 45–99) in complex with
ASH2L (residues 509–524) at a resolution of 2.4 A˚ (Figure 1C).
The asymmetric unit is composed of eight DPY-30D/D:ASH2LSDI
complexes, with each complex presenting a 2:1 stoichiometry of
DPY-30 to ASH2L. Overall, each DPY-30
D/D
protomer consists of
three a helices connected by short intersecting loops (Figure 1C).
Together, the two DPY-30 protomers form a prototypical X-type,
four-helix bundle and a quasi-symmetric dimer. As judged fromAll rights reserved
Figure 2. Four Pockets Define the ASH2L
Binding Site in DPY-30
(A) Overall representation of ASH2LSDI in complex
with the DPY-30 dimerization/docking module.
Shown is a surface representation (gray) of DPY-
30D/D in which cyan boxes highlight the four
pockets. On the right, residues forming the four
pockets are indicated.
(B) Sequence alignment of DPY-30. Amino acid
conservation is illustrated with different shades of
blue so that dark, medium, and pale blue corre-
spond to 100%–90%, 90%–80%, and 80%–60%
of amino acid conservation, respectively.
(C) Immunoblot analysis of ASH2L after GST pull-
down experiments of bacterial extracts containing
either DPY-30 WT or mutants. Bound ASH2L was
detected using an anti-His antibody (top panel).
The center and bottom panels show the input for
ASH2L constructs and that an equivalent amount
of DPY-30 was bound to glutathione Sepharose
beads, respectively.
(D) Western blot analysis of WRAD integrity
following immunoprecipitation by M2 Dynabeads
of HEK293 cell lysates transiently expressing
FLAG-tagged DPY-30 WT and mutants. The top
three panels indicate proteins retained by the M2
agarose beads, whereas the bottom three panels
show the input. RbBP5 and ASH2L were detected
with the indicated antibodies, whereas DPY-30
wild-type or mutants were detected with anti-
FLAG antibody.
(E) Monitoring of the impact of a single point mu-
tation in Cps25. The top panel indicates the level
of Set1. The center panel shows the overall level
of H3K4me3, and the bottom panel shows that
an equivalent amount of protein was loaded on
the gel. The western blots were performed with
ScSet1-, H3K4me3-, and histone H3-specific
antibodies.
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similar conformations with average root-mean-square devia-
tions (rmsds) of 0.3 A˚, demonstrating that binding of ASH2L
does not induce major structural reorganization of the DPY-30
dimerization/docking module (Figure S1 available online).
Examination of the density corresponding to ASH2LSDI shows
the location of residues 509–524 of ASH2L (Figure S2). ASH2LSDI
forms an amphipathic a helix nestled in an elongated cleft
formed by both DPY-30 protomers and lies 45 across one
face of the symmetrical homodimer (Figure 1C). Binding of the
ASH2L a helix occupies 680 A˚2 of the DPY-30D/D interface
that is formed predominantly by a core of hydrophobic residues.
Intriguingly, ASH2LSDI interaction with DPY-30 is symmetric, as
revealed by a quasi-two-fold symmetry of the ASH2L primary
structure centered on residues A514 and D515. These two resi-
dues are located in the position on ASH2LSDI that divides the
DPY-30D/D dyad axis within the ASH2L/DPY-30 complex. FromStructure 22, 1821–1830, December 2, 2014 ªthis position, a pattern of four hydropho-
bic pockets (pocket I–IV [PI–PIV]) can be
discerned (Figure 2A). These pockets
are predominantly formed by residues
located in DPY-30D/D a helices a0 and
a1, which engage in several hydrophobicinteractions with the ASH2L a helix hydrophobic ridge. The PI
pocket is mainly formed by Leu57A, Leu66B, and Leu69B side
chains and makes several contacts with V509 (residues denoted
with a single letter refer to ASH2L, and the superscript indicates
the DPY-30 protomer involved in the interaction). At the core
of the cradle-like structure, the PII pocket binds T512 and L513
of ASH2L by forming a shallow depression shaped by Arg54A,
Leu57A, Val62A, Leu65B, and Leu69B side chains. In proximity
of the PII pocket, a pair of hydrophobic residues (V516
and L517) binds in a third pocket (PIII) composed of Val62
B,
Leu57B, Leu69A, Leu65A, and Leu66A side chains. Similar to
the PI pocket, PIV is occupied by a valine residue. In this pocket,
V520 is in close proximity to Leu69B and Ala70B side chains.
Overall, our observations highlight the pseudosymmetric
fold of DPY-30D/D/ASH2LSDI interactions and the extent of hy-
drophobic contacts underlying the formation of the ASH2L/
DPY-30 heterotrimer (Figure 2A).2014 Elsevier Ltd All rights reserved 1823
Figure 3. Impairing the ASH2L/DPY-30
Interaction Blunts Erythroid Terminal Differ-
entiation
(A) Binding studies of the ASH2L/DPY-30 complex
in vitro. Bound ASH2L was detected using an anti-
63His-tag antibody, and the input is indicated
below. The Ponceau staining shows that equiva-
lent amount of GST-DPY30 (WT) was used for the
pull-down assays.
(B) Zoomed view of the L513 binding pocket. The
carbon atoms of DPY-30 residues are highlighted
in green and gray (protomers A and B). ASH2L
L513 carbon atoms are colored in beige.
(C) Assessment of DPY-30 mutations on b-globin
gene expression. Quantitative RT-PCR was
performed on two independent experiments
performed in triplicate. Levels of ASH2L were de-
tected with an anti-FLAG tag antibody, and TFIIH
p89 was used as a loading control. Error bars
represent SD.
(D) Measure of the impact of the L513D mutation
on H3K4 trimethylation at the LCR of the b-globin
gene. Enrichment of H3K4me3 was measured by
ChIP as described previously (Sarvan et al., 2011)
with either the empty vector (KD) or constructs
corresponding to ASH2L-WT, ASH2L-V509D, or
L513D mutants. Error bars represent SD.
Structure
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for ASH2L/DPY-30 Complex Formation and Global
H3K4me3 in Yeast
After examining the structure of DPY-30D/D in complex with
ASH2L, we sought to probe the role of evolutionarily conserved
interfacial residues using a glutathione S-transferase (GST) pull-
down approach (Figure 2B). The GST-tagged wild-type (WT) or
mutants of DPY-30 were incubated with WT His-tagged
ASH2L, and binding was monitored by western blot using an
anti-His antibody. As shown in Figure 2C and consistent with
recent studies (Chen et al., 2012; South et al., 2010), binding
was observed when ASH2L was incubated with GST-DPY-30,
whereas no enrichment could be detected when binding reac-
tions were carried out with GST alone. Given the extent of the
interactions provided by residues forming the PI–PIV pockets,
we reasoned that replacing these hydrophobic residues with
an aspartic acid residue would disrupt the binding of ASH2L to
DPY-30. Accordingly, substitution of the PII and PIII residues
Val62 and Leu66 (Figure 2C) modestly impaired the binding of
ASH2L, whereas the same mutation of Leu69, a residue shaping
all pockets and making several contacts with the ASH2LSDI hy-
drophobic ridge, completely abrogated the binding of ASH2L.
In contrast to Leu69, substitution of Arg54 to alanine modestly
affected binding of ASH2L, indicating that the polar contacts
mediated by this residue’s side chain play a minor role in the sta-
bilization of the a helix within the DPY-30D/D module.
To further evaluate the impact of disrupting the interactions
between DPY-30 and ASH2L in cells, we transfected FLAG-
tagged constructs of DPY-30 corresponding either to the WT,
Leu69Asp, or Arg54Ala in HEK293 cells and performed immuno-
precipitation using anti-FLAG M2 magnetic beads. As shown in
Figure 2D, both DPY-30 WT and the Arg54Ala mutant pulled
down ASH2L and RbBP5, whereas the Leu69Asp mutant failed
to immunoprecipitate the ASH2L/RbBP5 heterodimer. Overall,1824 Structure 22, 1821–1830, December 2, 2014 ª2014 Elsevier Ltdthese results demonstrate the importance of Leu69 in maintain-
ing the integrity of the ASH2L/DPY-30 complex and suggest that
the interaction between DPY-30D/D and ASH2L is predominantly
mediated by hydrophobic interactions.
After determining that Leu69 is important for the formation of
the ASH2L/DPY-30 complex, we sought to measure the impact
of this mutation in vivo. In Saccharomyces cerevisiae, deletion of
the DPY-30 yeast homolog Cps25 is nonlethal but results in a
complete loss of H3K4me3 (South et al., 2010), and the residue
corresponding to Leu69 is Met138 (Figure 2B). We reintroduced
either Cps25 WT or a Cps25 Met138Asp mutant in a yeast strain
lacking Cps25 (Cps25KO) and probed for global histone
H3K4me3. As shown in Figure 2E, deletion of Cps25 leads to a
global loss of H3K4me3, and complementation of Cps25 WT re-
stores the level of this PTM to the WT level. However, consistent
with the pull-down experiments, Cps25 Met138Asp comple-
mentation could not restore H3K4me3, suggesting that this
mutation impairs Cps60/Cps25 interaction and the allosteric
regulation of Set1 trimethyltransferase activity.
A Mutation of the ASH2L Hydrophobic Ridge Impairs
ASH2L/DPY-30 Complex Formation and Decreases
b-Globin Transcription during Erythroid Cell Terminal
Differentiation
After monitoring the role of residues forming the inner face of
DPY-30D/D module, we sought to probe the roles of ASH2L res-
idues important for the interaction with DPY-30. Binding assays
show that substitution of polar amino acids such as H511 and
D515 to an alanine residue does not impair binding of ASH2L
to DPY-30 (Figure 3A). Similarly, replacement of residues inter-
acting with the PI and PIV pockets, such as V509 and V520,
to aspartic acid only modestly prevents the formation of the
ASH2L/DPY-30 complex (Figure 3A). Conversely, substitution
of L513, a residue that fits snugly within the PII pocketAll rights reserved
Figure 4. Differences in the Geometry of Dimerization/Docking
Domains Control the Binding of Amphipathic a Helices
Shown are two orthogonal views of an overlay of RIa/AKAP2 and DPY-30/
ASH2LSDI complexes in which DPY-30 and RIa are highlighted in gray
and yellow, whereas AKAP2 and ASH2LSDI are colored in green and beige,
respectively.
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This result indicates that L513 is a key residue for the forma-
tion of the ASH2L/DPY-30 complex and further underlines the
importance of hydrophobic residues in the binding of ASH2L
to DPY-30.
DPY-30 regulates pathways in cellular senescence (Simboeck
et al., 2013) and ESC fate specification (Jiang et al., 2011), but its
role during erythroid terminal differentiation has not been exam-
ined. The MLL2 complex methylates H3K4 in the LCR of the
b-globin gene in murine erythroid leukemia cells and maintains
a high level of b-globin gene expression (Demers et al., 2007).
To test whether association of DPY-30 to ASH2L is important
for MLL2 activity, mouse erythroleukemia (MEL) cells carrying
a doxycycline-inducible small hairpin RNA (shRNA) specific
for ASH2L were ectopically transfected with FLAG-tagged Sh-
resistant constructs corresponding to WT, V509D and L513DStructure 22, 1821–18mutants of ASH2L. Following induction of differentiation, we
performed chromatin immunoprecipitation (ChIP) experiments
using H3K4me3 antibodies combined with quantitative RT-
PCR tomonitor the level of b-globin transcripts. As shown in Fig-
ure 3C and consistent with the role of ASH2L in the function
of the MLL2 complex (Demers et al., 2007), transfection of WT
ASH2L resulted in upregulation of b-globin gene expression
and an increased level of H3K4me3 at the LCR of the b-globin
gene (Figure 3D). Correlatively, the ASH2L V509D mutant dis-
played activity similar to the WT, whereas rescue with the
ASH2L L513D mutant failed to stimulate b-globin gene expres-
sion and H3K4me3 at the LCR of the b-globin gene. Taken
together, these results suggest that association of DPY-30
with the MLL2 complex regulates b-globin transcription during
terminal erythroid differentiation.
Comparison with the RIa/AKAP Complex
In an attempt to find the best structural homolog of DPY-30,
we performed a search using the DALI server (Holm and
Rosenstro¨m, 2010) and DPY-30D/D/ASH2LSDI coordinates. The
search yielded several results, with the regulatory region (RIa)
of PKA showing the highest structural similarities. The RIa of
PKA plays important roles in restricting the activity of the enzyme
in binding to the A kinase-anchoring proteins (AKAPs). Similar to
DPY-30, AKAP binds as an amphipathic helix and plays pivotal
roles in directing PKA to its suitable cellular localization and tar-
geting the enzyme to its substrates. Initial mapping experiments
performed on the a helix of AKAP revealed that substitution of
any residues lining the hydrophobic ridge to aspartic acid is
detrimental to the formation of the RIa-AKAP complex (Sarma
et al., 2010). Given that some mutations introducing acidic
residues on ASH2L retained binding to DPY-30, we reasoned
that structural differences exist between the binding modes of
RIa and DPY-30 dimerization/docking modules. Overall, DPY-
30D/D aligns with RIawith an rmsd of 2.58 A˚ for all Ca atoms, indi-
cating the presence of some structural differences. A structural
comparison with RIa shows that both D/D modules are
composed of two homodimers, each comprising three helices
(Figure 4). In contrast to DPY-30, RIa a0 is longer by one turn
of helix, which extends the cradle-like structure by8 A˚. In addi-
tion, the angle between DPY-30D/D a0 and a1 is more acute than
the corresponding a helices of RIa. Because of these structural
differences, the base of the DPY-30 cradle-like structure is wider
than the RIa binding cleft. However, despite these differences,
the ASH2LSDI and AKAP a helices superimpose well (Figure 4).
This similar positioning, combined with the structural differences
between DPY-30 and RIa, generate a longer distance between
the ASH2LSDI and the surface of DPY-30. These comparative an-
alyses suggest that structural differences in DPY-30 control its
ability to reside in specific protein complexes.
Identification of the Specificity Determinants for
Binding to DPY-30
In protein kinases A signaling pathways, differences in recogni-
tion of amino acid sequences between different regulatory do-
mains provide a mechanism for introducing specificity to the
enzyme (Gold et al., 2006; Kinderman et al., 2006). To systemat-
ically evaluate themotif recognized byDPY-30, we developed an
overlay assay. Recombinant GST-DPY-30 was incubated with30, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1825
Figure 5. Two Hydrophobic Pockets Define
the Binding Determinants Underlying the
Binding of DPY-30 to ASH2L and Integration
within the NURF Complex
(A) Two distinctive sets of hydrophobic residues
on ASH2L are important for binding to DPY-30.
Shown is a heatmap representation calculated
from an array in which each residue of ASH2LSDI
was systematically mutated to all other 20 natural
amino acids. Deviations are colored as in Fig-
ure 1A, with the exception that gain of binding was
colored in different shades of red or so that dark
red >10-fold, red >5-fold, and pink >3-fold. Raw
data are presented in Figure S3.
(B) Identification of the motif recognized by DPY-
30. The sequence logo representing the DBMs
was derived by the overlay assay. Letters are
scaled according to the intensity of the spots and
colored according to hydrophobicity, size, and
charge.
(C) Sequence alignment of putative DPY-30-inter-
acting proteins. Shown is the sequence alignment
ofDBMsof various proteins. Residues predicted to
bind DPY-30 pockets are shaded in gray.
(D) Binding of DPY-30 with the NURF complex in
HEK293 cells. Coimmunoprecipitation of BAP18
and BPTF by DPY-30 WT or Leu69Asp was
analyzed by immunoblots with the indicated anti-
bodies. The top three panels show the bound
fraction, whereas the bottom three panels show
that an equivalent amount of proteins has been
loaded.
(E) Validation of BAP18 as a direct DPY-30-inter-
acting protein. Binding of BAP18 to DPY-30 WT or
Leu69Asp was performed by GST pull-down ex-
periments using protein expressed in bacteria and
measured with the indicated antibody.
(F) Characterization of the BAP18 DBM. Binding
assays were performed as in Figure 5E with either
BAP18 WT or the Phe57Asp mutant and detected
with the indicated antibody.
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DPY-30 Binds the NURF and COMPASS-like Complexesan array of ASH2L peptide derivatives crosslinked to cellulose
where each residue in ASH2LSDI (503–523) was replaced by all
20 amino acids. Binding was measured using a horseradish
peroxidase (HRP)-coupled anti-GST antibody and quantified
by phosphorimaging (Figure S3). As shown in Figure 5A, we
found a strong correlation between the overlay assay and the
crystal structure of the DPY-30D/D/ASH2LSDI complex. Muta-
tions of residues preceding V508, a residue that does not
make a noticeable interaction with DPY-30D/D, have little impact
on the binding of DPY-30. Similarly, any substitutions of solvent-
exposed residues, with the exception of a proline, do not prevent
the binding of ASH2L (Figure 5A). Conversely, mutation of amino
acids interacting with DPY-30D/D pockets to residues other than
hydrophobic ones is detrimental, to different magnitudes, for the
binding of ASH2L to DPY-30. For example, mutation of the PI-in-
teracting residue V509 to an aspartic acid or other bulky charged
residues has a mild impact on the binding of DPY-30, whereas1826 Structure 22, 1821–1830, December 2, 2014 ª2014 Elsevier Ltd All rights reservedthe same substitutions on residues inter-
acting with PII and PIII pockets result in
a complete loss of binding. Notably,replacement of L513 (a PII pocket binding residue) by any resi-
dues other than a methionine or an isoleucine results in a drastic
loss of binding to DPY-30. A similar selectivity is observed for
the PIV-interacting residues. PIV is highly restrictive and is only
able to accommodate hydrophobic residues. Although mutation
of residues forming the hydrophobic ridge showed the most
noticeable impact upon mutation, replacement of D515 ex-
hibited a peculiar pattern. Substitution of this residue with any
nonhydrophobic residues did not impair the binding of DPY-
30, whereas its replacement with any hydrophobic residue led
to a 4- to 5-fold loss of DPY-30D/D binding, suggesting that the
spacing between clusters of hydrophobic residues is important
to maintain high-affinity binding (Figure 5A). Interestingly, with
the exception of a proline and glycine residues, substitution of
Y518 resulted in a significant gain of binding. In sum, these ob-
servations show that the hydrophobic residues near the sym-
metric dyad are critical for binding to DPY-30 and highlight a
Structure
DPY-30 Binds the NURF and COMPASS-like Complexespattern of residues, which will now be referred to as DPY-
30 binding motif (DBM), important for interaction with DPY-
30. The DBM consists of [YVLIFEA]-X-X-[fTSWM]-[VML]-
X-[c]-[VILMA]-[VMLI]-X-X-[VMLIF], where f and c represent
any hydrophobic and nonhydrophobic residues, respectively
(Figure 5B).
DPY-30D/D Is a Versatile Protein-Protein Interaction
Module
After determining the sequence rules for binding specificity by
DPY-30, we sought to explore whether known DPY-30-interact-
ing proteins harbored this motif. We queried a list of DPY-30 in-
teractors (van Nuland et al., 2013) with the DBM using Prosite
(Sigrist et al., 2013). Interestingly, we found several proteins
harboring this motif, including BIG1, BAP18, NCoA6, and
HDAC1. Manual inspection of other DPY-30 interactors charac-
terized in worms revealed that sex determination and dosage
compensation 2 (Sdc2) also harbors a DBM (Figure 5C).
To test whether one of the candidates, BAP18, can bind DPY-
30, we immunoprecipitated transiently expressed FLAG-tagged
DPY-30 WT or the Leu69Asp mutant in HEK293 cells. As shown
in Figure 5D, BAP18 and BPTF copurified with the WT, whereas
the same interactions were lost with the DPY-30 mutant. To
further verify whether DPY-30 directly interacts with BAP18,
we performed GST pull-down experiments with proteins ex-
pressed in bacteria. Similar to the FLAG immunoprecipitation
experiments, we observed binding of BAP18 to DPY-30.
Conversely, no binding could be detected in binding reactions
carried out with the DPY-30 Leu69Asp mutant (Figure 5E).
Finally, to validate our motif, we repeated these binding assays
with BAP18 Phe57Asp, a mutation predicted to impair the inter-
action with DPY-30D/D PI-PII pockets. As shown in Figure 5F, we
observed a notable loss of interaction between DPY-30 and the
BAP18 mutant, strongly suggesting that DPY-30 directly inter-
acts with BAP18 and is a genuine subunit of the NURF complex.
Finally, these results suggest that DPY-30 directly interacts with
several proteins (e.g., HDAC1 and NCoA6). However, additional
binding studies are needed to support this hypothesis.
DISCUSSION
The DPY30D/D/ASH2LSDI complex structure described here pro-
vides a structural framework for understanding the molecular
determinants for the recognition of the ASH2LSDI motif by the
DPY-30D/D module. This study also presents evidence that
the binding elements in DPY-30D/D mainly comprise four shallow
pockets, each accommodating hydrophobic residues distanced
by one turn of the a helix on ASH2LSDI. Of these pockets, PIII is
critical in binding ASH2L because a single Leu69Asp substitution
impairs binding to ASH2L in HEK293 cells and because the mu-
tation Met138Asp in Cps25 results in a complete loss of global
histone H3K4me3 in budding yeast. Similarly, replacement of
the ASH2L residue interacting with the PIII (L513) pocket impairs
H3K4me3 at the b-globin gene and results in a loss of b-globin
expression. Overall, our mutational analysis indicates that the
interaction between ASH2L and DPY-30 is critical for maintain-
ing a high level of histone H3K4me3 and contributes to the allo-
steric regulation of MLL1methyltransferase activity. Our findings
are also consistent with recent studies showing that knockdownStructure 22, 1821–18of ASH2L or DPY-30 results in a significant loss of H3K4me3 in
mouse embryonic stem cells and in human teratocarcinoma
NT2 cells (Jiang et al., 2011; Simboeck et al., 2013). How does
DPY-30 contribute to the high level of H3K4me3? The cryo-EM
analysis of the core COMPASS architecture showed that the
Cps60/Cps25 complex sits at the base of COMPASS and forms
a globular structure that is in close proximity to the Set1 catalytic
domain (Takahashi et al., 2011). Combinedwith the crystal struc-
ture of the ASH2L/DPY-30 complex, these observations suggest
that ASH2LSDI serves as an anchoring platform to recruit DPY-
30. This binding event allows the DPY-30 N terminus, the DPY-
30D/D/ASH2L complex, or both to directly contact and stimulate
MLL1 trimethyltransferase activity. Consistent with this model,
South et al. (2010) have shown recently that mutations impacting
the interaction between Cps60 and Cps25 are also detrimental
for the binding to ScSET1. Alternatively, association of DPY-30
to ASH2L triggers a structural reorganization of the ASH2L/
RbBP5 complex, ultimately leading to the opening of the Set1
catalytic site and resulting in a stimulation of its trimethyltransfer-
ase activity.
Binding of A-kinase anchoring proteins to RIa regulates PKA
and, consequently, controls a myriad of signaling events in facil-
itating the localization of the kinase to specific sites in the cell
(Smith et al., 2006). The crystal structure of DPY-30D/D in com-
plex with ASH2LSDI showed that, similar to the RIa and D/D do-
mains, DPY-30 binds the hydrophobic ridge of an amphipathic a
helix (Gold et al., 2006; Kinderman et al., 2006) and exhibits
sequence specificity regarding the hydrophobic residues recog-
nized by its X bundle structure. However, a detailed mutational
analysis combined with overlay assays revealed that DPY-
30D/D, in contrast to the RIa D/D domain, recognizes a divergent
set of residues. More specifically, the DPY-30D/D PI pocket is far
less restrictive than the RIa-analogous pocket. Indeed, although
RIa only accommodates an alanine residue in the second posi-
tion binding to the PI pocket, the DPY-30
D/D PI pocket enables
the binding of several bulky hydrophobic residues. Analogous
to the PI pocket, the other pockets of RIa all accommodate the
binding of small side chain residues, whereas overlay assays
performed with DPY-30 revealed that none of these pockets
are amenable for binding residues with small side chains. These
observations are further supported by a comparative analysis
between the RIa and DPY-30 X bundle structures (Burns-Ha-
muro et al., 2003, 2005; Sarma et al., 2010), which shows that
the distance between ASH2LSDI and the DPY-30 X bundle sur-
face is greater than the distance between AKAP and RIa. Our
data show that the difference in the angle between a0 and a1
of a dimerization/docking module will determine the relative
positioning of the binding a helix and contribute to, along with
the four binding pockets, the specificity of interactions of this
large family of scaffolding domains. It is interesting to note that
the effects of substituting hydrophobic residues of ASH2L in
pull-down experiments were less detrimental when compared
with the results observed with the overlay assays. In fact,
although the V516D substitution, a PIII-interacting residue, had
a negligible effect on DPY-30 binding using pull-down assays,
mutation of the same residue in overlay assays revealed that
only hydrophobic residues are accommodated in this pocket.
These differences suggest that other subunits binding to
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Table 1. Data Collection and Refinement Statistics
Dpy-30D/D-Ash2LSDI
Data Collection
Space group P1
Cell dimensions
a, b, c (A˚) 56.3, 56.8, 95.1
a, b, g () 90.1, 89.9, 115.4
Resolution (A˚) 28.9–2.40 (2.49–2.40)a
Rsym 7.3 (39.9)
I/sI 8.3 (1.9)
Completeness (%) 95.0 (93.4)
Redundancy 2.1 (2.1)
Refinement
Resolution (A˚) 22.9–2.4
No. of reflections 47655
Rwork/Rfree 24.6–29.6
No. of atoms
DPY-30 5,919
Ash2L 1,503
Water 29
Sulfate 40
B factors (A˚2)
Dpy-30 75.5
Ash2L 67.7
Water 63.3
Sulfate 113.1
Rmsds
Bond lengths (A˚) 0.01
Bond angles () 1.19
Molprobity score 1.94
Ramachandran (%)
Most allowed region 96.6
Allowed region 3.4
The data set was collected on a single crystal.
aThe highest resolution shell is shown in parentheses.
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DPY-30 Binds the NURF and COMPASS-like ComplexesDPY-30 directly interacts with ASH2L (Chen et al., 2012; South
et al., 2010), AKAP95 (Jiang et al., 2013), and BIG1 (Xia et al.,
2010; Xu et al., 2009), a protein localized in the trans-Golgi
network. In Caenorhabditis elegans, DPY-30 associates with
the dosage compensation complex (Pferdehirt et al., 2011), and
in Drosophila, the same protein binds to the metal-responsive
transcription factor 1 (Vardanyan et al., 2008). In addition, recent
proteomics studies showed that DPY-30 immunoprecipitates
several proteins, including many subunits of the NURF complex.
In combining the motifs established with the overlay assays and
the proteomics data,we found that DPY-30directly interactswith
BAP18, suggesting thatDPY-30 is a subunit of theBPTFcomplex
and that this protein may associate with several proteins. This
idea is further supported by recent studies demonstrating that
knockdown of DPY-30 downregulates ID proteins and results in
a senescent state (Simboeck et al., 2013). Attempts to rescue
the phenotype by ectopic expression of ID proteins only partly
rescued the phenotype, suggesting that DPY-30 controls senes-1828 Structure 22, 1821–1830, December 2, 2014 ª2014 Elsevier Ltdcence through other pathways or protein complexes. Accord-
ingly, given its association to several functionally different pro-
teins, future studies aimed at characterizing DPY-30 must take
into consideration the functional diversity of this protein. Finally,
considering the pervasiveness of amphipathic a helices in pro-
teins, the extent of protein complexes in which DPY-30 resides
has likely been underestimated, raising the possibility that DPY-
30 plays a versatile role in several biological processes.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Using primer-overlapping PCR, a DNA sequence encoding the ASH2LSDI was
placed in tandem with the cDNA corresponding to the D/D domain of DPY-30
(residues 45–99 (DPY-30D/D)). The construct, which was engineered so that a
tobacco etch virus protease (TEV) cleavage site separates ASH2LSDI and DPY-
30D/D, was cloned in a pGEX-based vector for expression of protein in fusion
with a TEV-cleavable GST affinity tag. The GST fusion ASH2LSDI-DPY-30D/D
protein was overexpressed in Rosetta cells for 3 hr at 37Cwith 100 mM isopro-
pyl b-D-1-thiogalactopyranoside. The cells were centrifuged, and the pellet
was harvested in PBS buffer (pH 7.3). The cells were lysed by sonication
and clarified by centrifugation. The supernatant was applied onto glutathione
Sepharose beads for 1 hr. After extensively washing the beads, the fusion pro-
tein was incubated with TEV protease in 20mM Tris (pH 7.0) and 100mMNaCl
for 16 hr at 4C. Cleaved proteins were concentrated, separated by size exclu-
sion chromatography (Superdex S75) pre-equilibrated in the same buffer.
Crystallization, Data Collection, and Crystal Structure
Determination
Following gel filtration, fractions of the main peak were pooled and immedi-
ately dialyzed in 20 mM (2-[N-morpholino]ethanesulfonic acid (pH 6.0) and
100 mM NaCl. The complex was subsequently concentrated to 10 mg/ml,
and crystallization trials were carried out using various sparse matrix screens.
Initial hits were obtained using Index Screen (Hampton Research). Diffraction-
quality crystals were obtained by vapor diffusion, with the mother liquor
composed of 0.2 M MgCl2, 25% polyethylene glycol (PEG) 3350, 0.1 M Tris
(pH 8.5), and 10 mM spermidine. Triangular crystals were harvested, soaked
in themother liquor supplementedwith 20%PEG 400, and quickly flash-frozen
in liquid nitrogen. A full data set was collected on aMicromax 007-HF (Rigaku),
and images were recorded on a RAXIX IV++ instrument. The reflections were
indexed and scaled using d*TREK (Pflugrath, 1999).
A homology model of DPY-30D/D-ASH2LSDI was generated using the PKA-
RIIa structure in complex with a peptide corresponding to residues 5–19 of
D-AKAP2. The DPY-30D/D domain (Protein Data Bank [PDB] ID code 3G36)
was overlaid onto the PKA-RIIa structure (PDB ID code 2HWN), and AKAP2
residues were mutated to alanine. The resulting heterotrimer was used as a
search model using Phaser (Zwart et al., 2008). Eight heterotrimers were
located in the asymmetric unit and were used as model building in Coot (Ems-
ley et al., 2010) and refined with Buster (Blanc et al., 2004). Omit maps were
calculated with Phenix (Figure S2), and the quality of the model was assessed
using Molprobity (Table 1).
GST Pull-Down Experiment
ASH2L was overexpressed as described previously (Sarvan et al., 2011).
Pellets were resuspended in 50 mM sodium phosphate, 500 mM NaCl, and
5 mM b-mercaptoethanol, and cells were lysed by sonication. Constructs cor-
responding to full-length DPY-30 (WT and mutants) were expressed in fusion
with GST in BL21(DE3) Rosetta cells, and the bacterial extracts were centri-
fuged, harvested, in PBS, and lysed by sonication. The supernatant was bound
to glutathione Sepharose beads (GE Healthcare) for 1 hr at 4C in PBS and
0.1%Triton X-100. The beads were washed using a binding buffer composed
of 50 mM Tris (pH 8.0), 300 mM NaCl, and 0.02% Triton X-100 and incubated
immediately for 2 hr at 4C with bacterial extracts containing His-tagged
ASH2L. The beads were subsequently washed with the binding buffer, and
bound proteins were eluted in SDS loading buffer. Proteins were separated
on SDS page gel and detected by western blot with appropriate antibodiesAll rights reserved
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DPY-30 Binds the NURF and COMPASS-like Complexes(see below). GST pull-down experiments for BAP18/DPY-30 interactions were
performed using similar conditions.
Antibodies
The commercial antibodies used in these studies included H3K4me3 (Abcam,
catalog no. ab8580), H3 (Millipore, catalog no. 05-928), FLAG (Sigma, catalog
no. F3165), histidine (Santa Cruz Biotechnology, catalog no. sc-803), GST/
HRP (Abcam, catalog no. ab3416), and BAP18 (Bethyl Laboratories). ScSet1
and histone H3 antibodies were provided by the A.S. laboratory.
Terminal Differentiation of Erythroid Cells
Sixteen micrograms of constructs corresponding to FLAG-empty (pCMV),
FLAG-ASH2L WT, FLAG-ASH2L V509D (retains binding activity on DPY-30),
and FLAG-ASH2L L513D (unable to bind DPY-30) were introduced into MEL
cells by electroporation. Twelve hours after electroporation, erythroid differen-
tiation was induced by adding 2% final DMSO to the culture medium. At the
same time, the knockdown of endogenous Ash2L was induced by adding
5 mg/ml final doxycycline to the culture medium. Forty-eight hours later, MEL
cells were centrifuged, harvested, and crosslinked as described previously
(Demers et al., 2007). Chromatin extraction, H3K4me3 immunoprecipitation,
and real-time quantitative PCR analysis were performed as described previ-
ously (Sarvan et al., 2011).
Budding Yeast Strain Engineering
Cps25 WT was cloned into the pRS406 vector, and the Cps25 Met138Asp
mutant was generated by site-directed mutagenesis (Agilent Technologies).
The vectors containing Cps25 WT or Met138Asp under the control of the
URA3 promoter were transformed into Cps25 d cells and grown on a synthetic
defined plate deficient of URA3 (SD-URA), and positive single-colony isolates
were selected and confirmed by PCR. Complemented cells were cultured in
YPD overnight at 30C, and nuclear extracts were isolated and analyzed by
western blotting using specific antibodies.
Design and Synthesis of the SPOT Arrays
The peptide arrays were synthesized using a SPOT synthesis technique
(Frank, 2002; Hilpert et al., 2007) (Kinexus). Briefly, the synthesis was carried
out using a MultiPep peptide synthesizer (INTAVIS Bioanalytical Instruments).
The peptides were built by subsequent delivery of 0.1 ml of 0.3 M solutions of
preactivated amino acids to each spot on a trioxa-tridecanediamine mem-
brane, an amino-functionalized cellulose membrane (Winkler and Hilpert,
2010). The linkage of the peptides to the TODT membrane is very stable
and, for that reason, particularly useful for direct probing on the membrane.
The distance between centers of two spots was 2.8 mm, and the diameter
of each spot was about 2 mm. The density of peptides was about 500 nmol/
cm2, which resulted in an amount of approximately 16 nmol of peptide
per spot.
Overlay Assays
Binding of GST-DPY-30 with the arrays was performed as follows. The arrays
were first blocked for 1 hr in Tris-buffered saline (TBS)-Tween (TBS-T) supple-
mented with 5%BSA at 22C. GST-DPY30 was then added at a concentration
of 2.5 mg/ml in TBS-T supplemented with 2.5% BSA and incubated with the
arrays for 105 min. Following the incubation, the arrays were washed with
TBS-T three times for 10 min each. An antibody against GST coupled to
HRP was then used at 0.2 mg/ml in 2% BSA/TBS-T for 1 hr, followed by three
washes of 10min each in TBS-T. Finally, a chemiluminescence substrate and a
Li-Cor Odyssey Fc imaging system were used to detect and quantify the inter-
action between the ASH2LSDI peptides and the DPY-30 protein. The assay, in
which every amino acid of the ASH2LSDI (positions 503–523) is substituted sys-
tematically and individually, was performed in duplicate, and the assay for the
optimization of the binding with 15 different SDI peptides was repeated four
times.
Immunoprecipitation of BAP18
Cells expressing FLAG-DPY-30 were harvested and lysed in radioimmunopre-
cipitation assay (RIPA) buffer. The supernatant was applied to anti-FLAG M2
magnetic beads (Invitrogen) for 1 hr andwashed twice with RIPA buffer. Bound
proteins were eluted with RIPA buffer supplemented with the FLAG peptideStructure 22, 1821–18for 1 hr. Eluted proteins were separated by SDS-PAGE and detected with
the indicated antibodies.
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